HCSGD entry for DUSP3
1. General information
Official gene symbol | DUSP3 |
---|---|
Entrez ID | 1845 |
Gene full name | dual specificity phosphatase 3 |
Other gene symbols | VHR |
Links to Entrez Gene | Links to Entrez Gene |
2. Neighbors in the network
This gene isn't in Literature mining network.
3. Gene ontology annotation
GO ID | GO term | Evidence | Category |
---|---|---|---|
GO:0000188 | Inactivation of MAPK activity | IMP | biological_process |
GO:0001701 | In utero embryonic development | IEA | biological_process |
GO:0001772 | Immunological synapse | IDA | cellular_component |
GO:0002224 | Toll-like receptor signaling pathway | TAS | biological_process |
GO:0002755 | MyD88-dependent toll-like receptor signaling pathway | TAS | biological_process |
GO:0002756 | MyD88-independent toll-like receptor signaling pathway | TAS | biological_process |
GO:0004725 | Protein tyrosine phosphatase activity | IDA IEA | molecular_function |
GO:0005634 | Nucleus | IDA | cellular_component |
GO:0005654 | Nucleoplasm | TAS | cellular_component |
GO:0005829 | Cytosol | IDA | cellular_component |
GO:0006470 | Protein dephosphorylation | IEA | biological_process |
GO:0008138 | Protein tyrosine/serine/threonine phosphatase activity | IDA IEA IMP | molecular_function |
GO:0033549 | MAP kinase phosphatase activity | IMP | molecular_function |
GO:0034134 | Toll-like receptor 2 signaling pathway | TAS | biological_process |
GO:0034138 | Toll-like receptor 3 signaling pathway | TAS | biological_process |
GO:0034142 | Toll-like receptor 4 signaling pathway | TAS | biological_process |
GO:0034146 | Toll-like receptor 5 signaling pathway | TAS | biological_process |
GO:0034162 | Toll-like receptor 9 signaling pathway | TAS | biological_process |
GO:0034166 | Toll-like receptor 10 signaling pathway | TAS | biological_process |
GO:0035335 | Peptidyl-tyrosine dephosphorylation | IDA | biological_process |
GO:0035666 | TRIF-dependent toll-like receptor signaling pathway | TAS | biological_process |
GO:0038123 | Toll-like receptor TLR1:TLR2 signaling pathway | TAS | biological_process |
GO:0038124 | Toll-like receptor TLR6:TLR2 signaling pathway | TAS | biological_process |
GO:0043409 | Negative regulation of MAPK cascade | IMP | biological_process |
GO:0045087 | Innate immune response | TAS | biological_process |
GO:0045931 | Positive regulation of mitotic cell cycle | IMP | biological_process |
GO:0046329 | Negative regulation of JNK cascade | IDA IMP | biological_process |
GO:0048011 | Neurotrophin TRK receptor signaling pathway | TAS | biological_process |
GO:0050860 | Negative regulation of T cell receptor signaling pathway | IDA | biological_process |
GO:0050868 | Negative regulation of T cell activation | IDA | biological_process |
GO:0051403 | Stress-activated MAPK cascade | TAS | biological_process |
GO:0070373 | Negative regulation of ERK1 and ERK2 cascade | IDA | biological_process |
Entries Per Page
Displaying Page of
4. Expression levels in datasets
- Meta-analysis result
p-value up | p-value down | FDR up | FDR down |
---|---|---|---|
0.0013803161 | 0.8697158619 | 0.1000862259 | 1.0000000000 |
- Individual experiment result
( "-" represent NA in the specific microarray platform )
( "-" represent NA in the specific microarray platform )
Data source | Up or down | Log fold change |
---|---|---|
GSE11954 | Up | 0.4397986288 |
GSE13712_SHEAR | Up | 0.3885764145 |
GSE13712_STATIC | Up | 0.0748393634 |
GSE19018 | Up | 0.0862405976 |
GSE19899_A1 | Up | 1.2533004498 |
GSE19899_A2 | Up | 2.4838309954 |
PubMed_21979375_A1 | Up | 0.7161289444 |
PubMed_21979375_A2 | Up | 2.0017778266 |
GSE35957 | Down | -0.2950348405 |
GSE36640 | Up | 1.3473602899 |
GSE54402 | Up | 1.0920619440 |
GSE9593 | Up | 0.8752433408 |
GSE43922 | Up | 0.4246568880 |
GSE24585 | Down | -0.0052087197 |
GSE37065 | Up | 0.1107638146 |
GSE28863_A1 | Down | -0.6797546414 |
GSE28863_A2 | Up | 0.5171182037 |
GSE28863_A3 | Down | -1.0436308559 |
GSE28863_A4 | Up | 0.2148778206 |
GSE48662 | Down | -0.0006176582 |
5. Regulation relationships with compounds/drugs/microRNAs
- Compounds
Not regulated by compounds
- Drugs
Not regulated by drugs
- MicroRNAs
- mirTarBase
MiRNA_name | mirBase ID | miRTarBase ID | Experiment | Support type | References (Pubmed ID) |
---|---|---|---|---|---|
hsa-miR-361-5p | MIMAT0000703 | MIRT020096 | Sequencing | Functional MTI (Weak) | 20371350 |
hsa-miR-125a-5p | MIMAT0000443 | MIRT021310 | Sequencing | Functional MTI (Weak) | 20371350 |
hsa-miR-10a-5p | MIMAT0000253 | MIRT025606 | Sequencing | Functional MTI (Weak) | 20371350 |
hsa-miR-421 | MIMAT0003339 | MIRT039365 | CLASH | Functional MTI (Weak) | 23622248 |
Entries Per Page
Displaying Page of
- mirRecord
No target information from mirRecord
6. Text-mining results about the gene
Gene occurances in abstracts of cellular senescence-associated articles: 3 abstracts the gene occurs.
PubMed ID of the article | Sentenece the gene occurs |
---|---|
18505570 | Cervix carcinoma is associated with an up-regulation and nuclear localization of the dual-specificity protein phosphatase VHR |
18505570 | BACKGROUND: The 21-kDa Vaccinia virus VH1-related (VHR) dual-specific protein phosphatase (encoded by the DUSP3 gene) plays a critical role in cell cycle progression and is itself regulated during the cell cycle |
18505570 | We have previously demonstrated using RNA interference that cells lacking VHR arrest in the G1 and G2 phases of the cell cycle and show signs of beginning of cell senescence |
18505570 | METHODS: In this report, we evaluated successfully the expression levels of VHR protein in 62 hysterectomy or conization specimens showing the various (pre) neoplastic cervical epithelial lesions and 35 additional cases of hysterectomy performed for non-cervical pathologies, from patients under 50 years of age |
18505570 | We used a tissue microarray and IHC technique to evaluate the expression of the VHR phosphatase |
18505570 | Immunofluorescence staining under confocal microscopy, Western blotting and RT-PCR methods were used to investigate the localization and expression levels of VHR |
18505570 | In the invasive cancer, VHR is also highly expressed with nuclear localization in the majority of cells compared to normal tissue where VHR is always in the cytoplasm |
18505570 | The immunofluorescence technique under confocal microscopy shows that VHR has a cytoplasmic localization in primary keratinocytes, while it localizes in both cytoplasm and nucleus of the cancer cell lines investigated |
18505570 | We report that the up-regulation of this phosphatase is mainly due to its post-translational stabilization in the cancer cell lines compared to primary keratinocytes rather than increases in the transcription of DUSP3 locus |
18505570 | CONCLUSION: These results together suggest that VHR can be considered as a new marker for cancer progression in cervix carcinoma and potential new target for anticancer therapy |
17658517 | Cells were induced to senescence by inhibition of phosphatase activity (VHR, MKP3, or PP2A) without additional cellular stress |
17012840 | Regulation of MAP kinases by the VHR dual-specific phosphatase: implications for cell growth and differentiation |
17012840 | We recently found that the expression of the 21-kDa human Vaccinia H1-related (VHR) dual-specific phosphatase fluctuates during cell cycle progression and affects Erk and Jnk activity in a cell cycle-dependent manner |
17012840 | Cells lacking VHR arrested at the G(1)/S and G(2)/M transitions of the cell cycle and exhibited senescence phenotypes |
17012840 | Cells lacking VHR upregulated p21(Cip/Waf1) and downregulated many genes for cell cycle regulators, DNA replication, transcription, and mRNA processing |
17012840 | In the absence of VHR, the serum-induced activation of Jnk and Erk was further elevated and was required for the G(1)/S and G(2)/M blocks, which were attenuated upon Jnk and Erk inhibition |
17012840 | Collectively, VHR provides a long sought layer in the regulation of Jnk and Erk during cell cycle progression thereby contributing to cell cycle arrest, differentiation or senescence |
Entries Per Page
Displaying Page of